Provided by Tiger Trade Technology Pte. Ltd.

ADiTx Therapeutics

3.08
+0.17005.84%
Post-market: 2.65-0.4300-13.96%19:59 EST
Volume:3.86M
Turnover:12.65M
Market Cap:1.72M
PE:0.00
High:3.48
Open:3.14
Low:2.92
Close:2.91
52wk High:10,311.25
52wk Low:2.36
Shares:559.40K
Float Shares:559.40K
Volume Ratio:0.70
T/O Rate:690.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4,919.3423
EPS(LYR):-346,053.3627
ROE:-282.21%
ROA:-61.70%
PB:-0.22
PE(LYR):0.00

Loading ...

Feb 24, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 20, 2023

Major Issues Report

8-K - Current report
Jan 06, 2023

Major Issues Report

8-K - Current report
Dec 23, 2022

Major Issues Report

8-K - Current report
Dec 20, 2022

Major Issues Report

8-K - Current report
Dec 02, 2022

Major Issues Report

8-K - Current report
Nov 14, 2022

Major Issues Report

8-K - Current report
Nov 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 03, 2022

Major Issues Report

8-K - Current report
Sep 27, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 26, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 20, 2022

Major Issues Report

8-K - Current report
Sep 16, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Sep 15, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Sep 15, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Sep 14, 2022

Correspondence

CORRESP [Cover] - Correspondence
Sep 14, 2022

Major Issues Report

8-K - Current report
Sep 07, 2022

Major Issues Report

8-K - Current report